Infection Control

From drug resistance to the growing threat of Candida auris, today's infection preventionists face a growing to-do list with limited resources. 

In a large hospital in London, removing mask rules for visitors and staff did not result in a "statistically significant change" in the rate of COVID-19 infections, a study published April 6 found, adding more questions to the swirling debate…

Observing military tank training prompted John Moses, PhD, a professor and researcher at Cold Spring Harbor (N.Y.) Laboratory, to develop "shape-shifting" antibiotics in an effort to fight rising instances of drug resistance.

The first human to be infected with a deadly plant fungus has made a full recovery after two years of treatment, The Jerusalem Post reported April 2.

Researchers have identified what may be the first documented human infection of a rare bacteria from an iguana bite, CNN reported April 2. 

As Paxlovid is "blunting SARS[-CoV-]2 disease pathogenesis," there are multiple transmissible coronavirus variants circulating resistant to the antiviral's main ingredient, according to a study published March 29 in Science Advances.

Meredith Hulsey, DO, has been named chief medical officer at Odessa, Texas-based Medical Center Hospital, according to Odessa American. Dr. Hulsey, a pathologist, was trained at MCH; she returned Jan. 3 to begin her new role, after five years away. 

Hospital leaders are ready for COVID-19 to go away and never come back. Becker's editorial statistics confirm interest in COVID-19 content has fallen in recent months. 

Health systems spend millions obtaining the latest technology to create state-of-the-art facilities and to build reputations for quality and innovation. But failing to maintain consistency in relatively low-tech, low-cost infection prevention strategies like hand hygiene can undermine reputation, patient outcomes…

This episode features Dr. Jose Alexander, Director - Clinical Microbiologist for AdventHealth Central Florida. In this conversation, he expands on his focus on brain-eating amoebas & how he and his team were able to use protocols from COVID-19 to better…